Clinical Trial Update: Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a vaccine therapy with bevacizumab versus bevacizumab alone in patients with surgically resectable recurrent glioblastoma; the study wa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Vaccine therapy

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Recurrent Glioblastoma, Recurrent Adult Brain Tumor | Phase 2 | Status: TERMINATED | Results posted: 2019-06-12